Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ouma SG"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-2 z 2
    Tytuł:
    Adults from Kisumu, Kenya have robust γδ T cell responses to Schistosoma mansoni, which are modulated by tuberculosis.
    Autorzy:
    McLaughlin TA; Emory Vaccine Center, Emory University, Atlanta, Georgia, United States of America.
    Khayumbi J; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
    Ongalo J; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
    Matete D; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
    Tonui J; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
    Muchiri B; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
    Sasser LE; Emory Vaccine Center, Emory University, Atlanta, Georgia, United States of America.
    Campbell A; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
    Allana S; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
    Ouma SG; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
    Hayara FO; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
    Gandhi NR; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
    Day CL; Emory Vaccine Center, Emory University, Atlanta, Georgia, United States of America.; Department of Microbiology & Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
    Pokaż więcej
    Źródło:
    PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 Oct 12; Vol. 14 (10), pp. e0008764. Date of Electronic Publication: 2020 Oct 12 (Print Publication: 2020).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Mycobacterium tuberculosis/*immunology
    Schistosoma mansoni/*immunology
    Schistosomiasis mansoni/*immunology
    T-Lymphocytes/*immunology
    Tuberculosis/*immunology
    Adult ; Animals ; Antibodies, Helminth ; Coinfection/immunology ; Coinfection/microbiology ; Coinfection/parasitology ; Female ; Humans ; Interferon-gamma/immunology ; Interleukin-4/immunology ; Kenya ; Male ; Middle Aged ; Mycobacterium tuberculosis/genetics ; Mycobacterium tuberculosis/physiology ; Schistosoma mansoni/genetics ; Schistosoma mansoni/physiology ; Schistosomiasis mansoni/parasitology ; Tuberculosis/microbiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Development of a TB vaccine trial site in Africa and lessons from the Ebola experience.
    Autorzy:
    Kaguthi G; Centre for Respiratory Diseases Research-Kenya Medical Research Institute (KEMRI-CRDR), Nairobi, Kenya. .; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. .; (at the time of the studies) KEMRI and Centers for Disease Control and Prevention Public Health Collaboration, Kisumu, Kenya. .
    Nduba V; Centre for Respiratory Diseases Research-Kenya Medical Research Institute (KEMRI-CRDR), Nairobi, Kenya.; (at the time of the studies) KEMRI and Centers for Disease Control and Prevention Public Health Collaboration, Kisumu, Kenya.
    Rabuogi P; Centre for Respiratory Diseases Research-Kenya Medical Research Institute (KEMRI-CRDR), Nairobi, Kenya.; (at the time of the studies) KEMRI and Centers for Disease Control and Prevention Public Health Collaboration, Kisumu, Kenya.
    Okelloh D; Centre for Respiratory Diseases Research-Kenya Medical Research Institute (KEMRI-CRDR), Nairobi, Kenya.; (at the time of the studies) KEMRI and Centers for Disease Control and Prevention Public Health Collaboration, Kisumu, Kenya.
    Ouma SG; Centre for Respiratory Diseases Research-Kenya Medical Research Institute (KEMRI-CRDR), Nairobi, Kenya.; (at the time of the studies) KEMRI and Centers for Disease Control and Prevention Public Health Collaboration, Kisumu, Kenya.
    Blatner G; AERAS (at the time of the studies), Cape Town, South Africa.; AERAS (at the time of the studies), Rockville, Maryland, USA.
    Gelderbloem S; AERAS (at the time of the studies), Cape Town, South Africa.; AERAS (at the time of the studies), Rockville, Maryland, USA.
    Mitchell EMH; Institute of Tropical Medicine, Antwerp, Belgium.; (at the time of the studies) KNCV Tuberculosis Foundation, The Hague, The Netherlands.
    Scott CP; AERAS (at the time of the studies), Cape Town, South Africa.; AERAS (at the time of the studies), Rockville, Maryland, USA.
    Verver S; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; (at the time of the studies) KNCV Tuberculosis Foundation, The Hague, The Netherlands.
    Hawkridge T; AERAS (at the time of the studies), Cape Town, South Africa.; AERAS (at the time of the studies), Rockville, Maryland, USA.
    de Steenwinkel JEM; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
    Laserson KF; (at the time of the studies) KEMRI and Centers for Disease Control and Prevention Public Health Collaboration, Kisumu, Kenya.
    Richardus JH; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
    Pokaż więcej
    Źródło:
    BMC public health [BMC Public Health] 2020 Jun 26; Vol. 20 (1), pp. 999. Date of Electronic Publication: 2020 Jun 26.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    BCG Vaccine/*therapeutic use
    Clinical Trials as Topic/*standards
    Disease Outbreaks/*prevention & control
    Immunization Programs/*standards
    Tuberculosis/*prevention & control
    Africa ; Disease Outbreaks/statistics & numerical data ; Ebola Vaccines ; Hemorrhagic Fever, Ebola/epidemiology ; Humans ; Tuberculosis/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-2 z 2

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies